Key result
Lower adiponectin levels were found to be the strongest independent predictor of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus (OR 1.673).
Why the study?
Type 2 diabetes mellitus is associated with chronic inflammation and oxidative stress implicated in NAFLD, prompting assessment of the role of adipokines, oxidative stress, and endotoxins in NAFLD pathogenesis in T2DM.
Are adipokines, oxidative stress, and endotoxins associated with the pathogenesis of NAFLD in patients with type 2 diabetes mellitus?
Cross-Sectional (n=150)
No
Are adipokines, oxidative stress, and endotoxins associated with the pathogenesis of NAFLD in patients with type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
In patients with type 2 diabetes, the presence of NAFLD is associated with significantly higher levels of endotoxins, oxidative stress, and inflammation, alongside lower adiponectin levels.
Background: Type 2 diabetes mellitus (T2DM) is associated with chronic inflammation and oxidative stress, implicated in the pathophysiology of non-alcoholic fatty liver disease (NAFLD). Present study aimed to assess the role of adipokines, oxidative stress, and endotoxins in the pathogenesis of NAFLD in T2DM.Methods: Present cross-sectional observational study included healthy controls (n=50; group 1); T2DM patients without NAFLD (n=50; group 2), T2DM patients with NAFLD (n=50; group 3). Study subjects were age and gender matched.Results: Tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), high sensitive C-reactive protein (hs-CRP), endotoxin, malondialdehyde (MDA) were significantly elevated and adiponectin, ferric reducing ability of plasma (FRAP), and glutathione (GSH) were significantly lower (p<0.001) in T2DM patients with NAFLD when compared to T2DM patients without NAFLD and controls. Endotoxin showed significant positive correlation with TNF-α (r=0.304; p<0.001), hs-CRP (r=0.193; p=0.018), and MDA (r=0.420; p<0.001), and significant negative correlation with adiponectin (r=-0.406; p<0.001). TNF-α and IL-6 showed significant positive correlation with MDA (r=0.526; p<0.001, r=0.229; p=0.005) and significant negative correlation with adiponectin (r=-0.396; p<0.001, r=-0.318; p<0.001), FRAP (r=-0.418; p<00.001, r=-0.170; p=0.038), and GSH (r=-0.353; p<0.001, r=-0.301; p<0.001).Conclusions: Authors observed elevated endotoxin, oxidative stress, inflammation and lower adiponectin levels in T2DM subjects compared to controls. These changes were more pronounced in T2DM with NAFLD when compared to T2DM without NAFLD. Lower adiponectin levels were found to be a better predictor of NALFD in T2DM and is associated with oxidative stress and systemic inflammation.
No takes yet. Share an insight, caveat, or question.
Pallavi et al. (2019) conducted a cross-sectional in Type 2 diabetes mellitus and non-alcoholic fatty liver disease (n=150). Non-alcoholic fatty liver disease (NAFLD) vs. T2DM without NAFLD and healthy controls was evaluated on Presence of NAFLD in T2DM (Adiponectin as a predictor) (OR 1.673, 95% CI 1.091-2.567, p=0.018). Lower adiponectin levels were found to be the strongest independent predictor of non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus (OR 1.673).
Synapse has enriched 10 related papers. Consider them for comparative context: